Cephalosporins: Indications, Dosing, and Precautions by Generation
Cephalosporins are beta-lactam antibiotics classified into five generations based on their antimicrobial spectrum, with first-generation agents like cefazolin being the preferred choice for surgical prophylaxis and gram-positive infections, while third-generation agents provide expanded gram-negative coverage for serious infections.
Classification and Spectrum of Activity
First-Generation Cephalosporins
- Primary agents: Cefazolin (IV), cephalexin (oral), cefadroxil (oral)
- Spectrum: Excellent activity against gram-positive cocci (Staphylococcus aureus, Streptococcus species) and select gram-negative organisms (E. coli, Proteus, Klebsiella) 12
- Key limitation: First-generation agents like cephalexin are inactive against B. burgdorferi and ineffective for Lyme disease 3
Second-Generation Cephalosporins
- Primary agents: Cefuroxime (IV/oral), cefoxitin, cefotetan
- Spectrum: Broader gram-negative coverage than first-generation while maintaining gram-positive activity 1
- Important caveat: B. fragilis group isolates show substantial resistance to cefoxitin and cefotetan; these should not be used empirically when B. fragilis is likely 4
Third-Generation Cephalosporins
- Primary agents: Ceftriaxone, cefotaxime, ceftazidime, cefepime (technically fourth-generation)
- Spectrum: Expanded gram-negative coverage including many resistant Enterobacteriaceae 1
- Special considerations:
Fourth-Generation Cephalosporins
- Primary agent: Cefepime
- Spectrum: Excellent activity against both gram-positive and gram-negative pathogens, including antibiotic-resistant Enterobacteriaceae 1
Fifth-Generation Cephalosporins
- Primary agents: Ceftaroline, ceftobiprole
- Unique feature: The only beta-lactams with activity against MRSA 6
- Use: Acceptable for MRSA bloodstream infections either as monotherapy or combination therapy 6
Key Clinical Indications and Dosing
Surgical Prophylaxis
Cefazolin is the gold-standard first-line agent for perioperative prophylaxis 78:
- Dose: 2 g IV within 60 minutes before incision; increase to 3 g if patient weighs ≥120 kg
- Redosing: Required if procedure exceeds 4 hours or blood loss >1500 mL 7
- Rationale: Proven reduction in surgical site infections and endometritis; cost-effective with high tissue penetration 7
- Evidence strength: Cefazolin demonstrates superior outcomes compared to non-cephalosporin alternatives in arthroplasty, with lower odds of prosthetic joint infection (OR 0.59; 95% CI 0.46-0.75) 9
Febrile Infants (8-60 Days Old)
8-21 days old:
- UTI: Ampicillin 150 mg/kg/day divided q8h + ceftazidime 150 mg/kg/day divided q8h
- Meningitis: Ampicillin 300 mg/kg/day divided q6h + ceftazidime 150 mg/kg/day divided q8h
22-28 days old:
- UTI: Ceftriaxone 50 mg/kg once daily
- Meningitis: Ampicillin 300 mg/kg/day divided q6h + ceftazidime 150 mg/kg/day divided q8h
29-60 days old:
- UTI: Ceftriaxone 50 mg/kg once daily (oral options: cephalexin 50-100 mg/kg/day in 4 doses)
- Meningitis: Ceftriaxone 100 mg/kg/day once daily or divided q12h + vancomycin 60 mg/kg/day divided q8h
Complicated Urinary Tract Infections
For patients without sepsis requiring IV therapy, third- or fourth-generation cephalosporins are preferred 11:
- Ceftriaxone, ceftazidime, cefotaxime, or cefepime
- Critical point: Oral cephalosporins (cephalexin) are alternatives for non-septic patients but may not achieve adequate renal parenchymal levels 11
Diabetic Foot Infections
Severity-based approach 12:
Mild infections without complications:
- First-generation cephalosporin (cephalexin) or cloxacillin
- Targets gram-positive cocci
Moderate-to-severe infections:
- Second/third-generation cephalosporins (cefuroxime, cefotaxime, ceftriaxone) + metronidazole for anaerobic coverage
- For ischemic limb/necrosis: Consider broader coverage with third-generation agents
Complicated Intra-Abdominal Infections
For community-acquired mild-to-moderate infections, use narrow-spectrum agents 4:
- Cefazolin or cefuroxime + metronidazole
For severe infections or immunosuppressed patients 4:
- Third/fourth-generation cephalosporins (cefotaxime, ceftriaxone, ceftazidime, cefepime) + metronidazole
- These provide broader gram-negative coverage
Critical Precautions and Cross-Reactivity
Penicillin Allergy Considerations
The risk of cross-reactivity between penicillins and cephalosporins is significantly lower than historically believed 5:
- Cefazolin has unique side chains and demonstrates very low cross-reactivity with penicillins despite being first-generation (0.7% reaction rate in unverified penicillin allergy; 0.8% in confirmed penicillin allergy) 5
- Aminocephalosporins (cephalexin, cefadroxil, cefprozil) share R1 side chains with aminopenicillins and have higher cross-reactivity (16.45%) 5
- Low-similarity cephalosporins (cefazolin, cefpodoxime, ceftriaxone, ceftazidime, cefepime) have cross-reactivity of only 2.11% 5
Practical approach: Cefazolin can be safely administered to most patients with reported penicillin allergy. Implementation studies show 85.8% of penicillin-allergic patients successfully received cefazolin without severe hypersensitivity reactions 13
Skin Testing Recommendations
Cephalosporin skin testing should only be used for parenteral cephalosporins 5:
- Recommended concentrations vary by agent (see Table XIII in evidence)
- Positive test suggests IgE antibodies; proceed with desensitization or alternative agent
- Negative test should be followed by drug challenge
Important exception: These recommendations do not apply to patients with severe delayed reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, drug-induced liver injury, acute interstitial nephritis) 5
Common Adverse Effects
- Gastrointestinal disturbances
- Dermatologic reactions
- Hypersensitivity reactions (rare anaphylaxis)
- Hematologic effects
- Potential disruption of microbiome 1010
- Development of antimicrobial resistance 1010
Special Populations
Pregnancy: Cephalosporins are generally safe; avoid doxycycline combinations 3
Renal impairment: Dose adjustments required for most cephalosporins except ceftriaxone and cefoperazone (biliary excretion) 14
Pediatrics: Avoid ceftriaxone in neonates with hyperbilirubinemia due to displacement from albumin binding sites
Antimicrobial Stewardship Principles
Use the narrowest spectrum agent effective for the indication 415:
- Reserve third-generation agents for documented resistant organisms or severe infections
- First-generation agents remain appropriate for most staphylococcal/streptococcal infections in penicillin-allergic patients
- Inappropriate prescribing occurs in 32.4% of cases, contributing to resistance 15
Culture-guided therapy: Empirical third-generation cephalosporin use should be de-escalated based on culture results 15
Avoid monotherapy for B. fragilis: Cephalosporins alone are inadequate; combine with metronidazole for anaerobic coverage 4
Duration: Most surgical prophylaxis requires only single-dose or 24-hour coverage; prolonged courses increase resistance risk 8